Citations

Clear

2416 citation(s) found for "Yu, Jason".

Teaching Video Neuro Images : Palatal tremor in adult-onset Alexander disease
Sebesto, Jason R., Gerpen, Jay A. van, Van Gerpen, Jay A

Mayo Clinic

Neurology | June 13, 2016 | Volume: 86 | Issue: 24 | Pages: No page available

10.1212/wnl.0000000000002763 | PMID 27298457 Get It

Multiple-level validation identifiesPARK2in the development of lung cancer and chronic obstructive pulmonary disease
Lee, SeungBaek, Deng, Bo , Kim, Jung-Jin, Sun, Zhifu , Wampfler, Jason A. , Cunningham, Julie M. , Wu, Yanhong , Aubry, Marie-Christine, Wendt, Chris H. , Biterman, Peter, Lee, Seung Baek , She, Jun, Kim, JungJin, de Andrade, Mariza, Na, Jie , Lee, SeungBaek , She, Jun , Andrade, Mariza de , Limper, Andrew H. , Yang, Ping , Lou, Zhenkun , Sun, Zhifu , Wendt, Chris H , Lee, Seung Baek

Mayo Clinic

Oncotarget | June 13, 2016 | Volume: 7 | Issue: 28 | Pages: 44211-44223

10.18632/oncotarget.9954 | PMID 27329585 Get It

An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase
Hasassri, M. Earth , Boyce, Thomas G. , Norgan, Andrew P. , Cunningham, Scott A. , Jeraldo, Patricio , Patel, Robin , Banerjee, Ritu , Pogue, Jason M. , Kaye, Keith S. , Jeraldo, Patricio R , Weissman, Scott J. , Patel, Robin , Norgan, Andrew P , Cunningham, Scott A

Mayo Clinic

Antimicrobial Agents and Chemotherapy | May 24, 2016 | Volume: 60 | Issue: 6 | Pages: 3270-3275

10.1128/aac.03118-15 | PMID 27217442 Get It

ABSTRACT We describe a 16-year-old neutropenic patient from the Middle East with bloodstream infection caused by two carbapenemase-producing Escherichia coli isolates that we characterized by whole-genome sequencing. While one displayed meropenem resistance and was bla NDM positive, the other demonstrated meropenem susceptibility yet harbored bla OXA181 (which encodes a bla OXA48 -like enzyme). This report highlights the challenge of laboratory detection of bla OXA48 -like enzymes and the clinical implications of genotypic resistance detection in carbapenemase-producing Enterobacteriaceae .
The BRG1 chromatin remodeling enzyme links cancer cell metabolism and proliferation
Wu, Qiong , Madany, Pasil, Dobson, Jason R. , Schnabl, Jake , Sharma, Soni , Wijnen, André J. van , Stein, Janet L. , Lian, Jane B. , Stein, Gary S., Muthuswami, Rohini , Imbalzano, Anthony N. , Nickerson, Jeffrey A. , van Wijnen, Andre J, Smith, Tara C., van Wijnen, Andre J

Mayo Clinic

Oncotarget | May 21, 2016 | Volume: 7 | Issue: 25 | Pages: 38270-38281

10.18632/oncotarget.9505 | PMID 27223259 Get It

Perioperative Outcomes in Intracranial Pleomorphic Xanthoastrocytoma
Gaba, Prakriti , Puffer, Ross C. , Hoover, Jason M. , Wharen, Robert E. , Parney, Ian F. , Parney, Ian F

Mayo Clinic

Neurosurgery | May 14, 2016 | Volume: 80 | Issue: 1 | Pages: 105-111

10.1227/neu.0000000000001250 | PMID 31859356 Get It

Abstract BACKGROUND: Patients with pleomorphic xanthoastrocytoma (PXA) routinely undergo multiple procedures to ensure recurrence-free survival and are resultantly at increased risk of experiencing perioperative complications (regional, medical, and/or neurological), a combination of which has not been recorded in previous studies. OBJECTIVE: To determine perioperative outcomes in a cohort of patients (adult and pediatric) with intracranial PXA. METHODS: We retrospectively identified 39 patients who underwent surgery at our institution for intracranial PXA between 1994 and 2011. Demographic factors were recorded along with Karnofsky Performance Status (KPS), complications, and mortality. RESULTS: Mean patient age was 31 years at the most recent surgery. A majority of patients (24; 62%) had multiple surgeries with a mean of 2 operations per patient. Eleven PXAs (28%) were malignant (grade III or IV). Perioperative complications included permanent neurological worsening in 4 patients (10%), regional complications in 4 (10%), and medical complications in 3 (8%). Preoperative KPS was ≥70 in 34 of 38 patients (89%). Long-term postoperative KPS was ≥70 in 36 of 37 patients (97%), suggesting good functional outcomes. There was no perioperative mortality, but 7 patients (18%) died of tumor progression. Patients with malignant PXAs trended toward higher risk of regional complications (3 of 11 patients [27%]; P = .06), received adjuvant therapy more often (10 of 11 patients [91%]; P < .001), had higher mortality from tumor progression (7 of 11 patients [64%]; P < .001), and were significantly larger (mean, 6.05 ± 0.73 cm standard error of the mean; n = 7; P < .01). CONCLUSION: Both pediatric and adult PXAs may be resected with good functional outcomes. Perioperative neurological complications are relatively common, but do not affect long-term functional outcome or mortality. Malignant PXAs are higher risk for perioperative complications and, ultimately, death from tumor progression, despite increased use of adjuvant radiation and chemotherapy.
Do Lumbar Decompression and Fusion Patients Recall Their Preoperative Status?
Aleem, Ilyas , Duncan, Jonathan, Ahmed, Amin Mohamed, Zarrabian, Mohammad , Eck, Jason C., Rhee, John M. , Currier, Bradford L. , Aleem, Ilyas S, Clarke, Michelle, Clarke, Michelle J. , Nassr, Ahmad

Mayo Clinic

Spine | May 12, 2016 | Volume: 42 | Issue: 2 | Pages: 128-134

10.1097/brs.0000000000001682 | PMID 27163372 Get It

Study Design. Prospective cohort study. Objective. To characterize the accuracy of patient recollection of preoperative symptoms after lumbar spine surgery. Summary of Background Data. Although patient-reported outcomes have become important in the evaluation of spine surgery patients, the accuracy of patient recall remains unknown. Methods. Patients undergoing lumbar decompression with or without fusion were enrolled. Back and leg Numeric Pain Scores and Oswestry Disability Indices were recorded preoperatively. Patients were asked to recall their preoperative status at a minimum of 1 year after surgery. Actual and recalled scores were compared using paired t tests and relations were quantified using Pearson correlation coefficients. Multivariable linear regression was used to identify factors that affected recollection. Results. Sixty-two patients with a mean age of 66.1 years were included. Compared to their preoperative scores, patients showed significant improvement in back pain (mean difference [MD] = −3.2, 95% CI −4.0 to −2.4), leg pain (MD −3.3, 95% CI −4.3 to −2.2), and disability (MD −25.0%, 95% CI −28.7 to −19.6). Patient recollection of preoperative status was significantly more severe than actual for back pain (MD +2.3, 95% CI 1.5–3.2), leg pain (MD +1.8, 95% CI 0.9–2.7), and disability (MD +9.6%, 95% CI 5.6–14.0). No significant correlation between actual and recalled scores with regards to back (r = 0.18) or leg (r = 0.24) pain and only moderate correlation with disability (r = 0.44) were seen. This was maintained across age, sex, and time between date of surgery and recollection. More than 40% of patients switched their predominant symptom from back pain to leg pain or leg pain to back pain on recall. Conclusion. Relying on patient recollection does not provide an accurate measure of preoperative status after lumbar spine surgery. Recall bias indicates the importance of obtaining true baseline scores and patient-reported outcomes prospectively and not retrospectively. Level of Evidence: 2
USP6 oncogene promotes Wnt signaling by deubiquitylating Frizzleds
Walker, Matthew P. , Quick, Laura , Orgel, Kelly, Ryan, Meagan B. , Gupta, Priti , Henrich, Ian C. , Marine, Shane, Roberts, Brian S. , Arthur, William T., Berndt, Jason D. , Oliveira, André M. , Virshup, David M. , Chou, Margaret M. , Major, Michael B. , Virshup, David M , Madan, Babita , Walker, Matthew P., Young, Robert , Ferrer, Marc , Moon, Randall T.

Mayo Clinic

Proceedings of the National Academy of Sciences | May 10, 2016 | Volume: 113 | Issue: 21 | Pages: No page available

10.1073/pnas.1605691113 | PMID 27162353 Get It

Significance Ubiquitin-specific protease 6 (USP6) is a deubiquitylase that is overexpressed by chromosome translocation in two human neoplasms, aneurysmal bone cyst and nodular fasciitis. The relevant substrates of this ubiquitin-specific protease are not clear. Here, we identify the Wnt receptor Frizzled (Fzd) as a key target of the USP6 oncogene. Increased expression of USP6 increases the membrane abundance of Fzd, and hence increases cellular sensitivity to Wnts. USP6 opposes the activity of the ubiquitin ligase and tumor suppressor ring finger protein 43 (RNF43). This study identifies a new mechanism for pathological Wnt pathway activation in human disease and suggests a new approach to regulate Wnt activity therapeutically.
Noncoding Transcription Is a Driving Force for Nucleosome Instability in spt16 Mutant Cells
Feng, Jianxun , Gan, Haiyun , Eaton, Matthew L. , Zhou, Hui , Li, Shuqi , Belsky, Jason A. , MacAlpine, David M. , Zhang, Zhiguo , Li, Qing , Zhang, Zhiguo

Mayo Clinic

Molecular and Cellular Biology | May 3, 2016 | Volume: 36 | Issue: 13 | Pages: 1856-1867

10.1128/mcb.00152-16 | PMID 27141053 Get It

Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors
Roife, David , Lv, Hailong , Ling, Jianhua , Perez, Mayrim V. Rios , Li, Xinqun, Dai, Bingbing , Pratt, Michael, Truty, Mark J. , Thomas, Ryan M. , Chiao, Paul J. , Katz, Matthew H. G. , Fleming, Jason B. , Kang, Ya’an , Lee, Yeon‐Ju , Suzuki, Rei , Chatterjee, Deyali , Wang, Huamin , Wang, Yu , Koay, Eugene J. , Katz, Matthew H G

Mayo Clinic

Clinical Cancer Research | April 29, 2016 | Volume: 22 | Issue: 19 | Pages: 4934-4946

10.1158/1078-0432.ccr-15-2780 | PMID 27126993 Get It

Abstract Purpose: Pancreatic ductal adenocarcinoma (PDAC) is lethal cancer whose primary tumor is characterized by dense composition of cancer cells, stromal cells, and extracellular matrix (ECM) composed largely of collagen. Within the PDAC tumor microenvironment, activated pancreatic stellate cells (PSC) are the dominant stromal cell type and responsible for collagen deposition. Lumican is a secreted proteoglycan that regulates collagen fibril assembly. We have previously identified that the presence of lumican in the ECM surrounding PDAC cells is associated with improved patient outcome after multimodal therapy and surgical removal of localized PDAC. Experimental Design: Lumican expression in PDAC from 27 patients was determined by IHC and quantitatively analyzed for colocalization with PSCs. In vitro studies examined the molecular mechanisms of lumican transcription and secretion from PSCs (HPSCs and HPaSteC), and cell adhesion and migration assays examined the effect of lumican on PSCs in a collagen-rich environment. Results: Here we identify PSCs as a significant source of extracellular lumican production through quantitative IHC analysis. We demonstrate that the cytokine, TGF-β, negatively regulates lumican gene transcription within HPSCs through its canonical signaling pathway and binding of SMAD4 to novel SBEs identified within the promoter region. In addition, we found that the ability of HPSCs to produce and secrete extracellular lumican significantly enhances HPSCs adhesion and mobility on collagen. Conclusions: Our results demonstrate that activated pancreatic stellate cells within PDAC secrete lumican under the negative control of TGF-β; once secreted, the extracellular lumican enhances stellate cell adhesion and mobility in a collagen-rich environment. Clin Cancer Res; 22(19); 4934–46. ©2016 AACR.